(S)-9-fluoro-10-(4-hydroxypiperidin-1-yl)-3-methyl-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: (S)-9-fluoro-10-(4-hydroxypiperidin-1-yl)-3-methyl-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
• 英文别名: (2S)-7-fluoro-6-(4-hydroxypiperidin-1-yl)-2-methyl-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid
• 化学式: C₁₈H₁₉FN₂O₅
• 分子量: 362.358
• InChiKey: DEHJWWJQQLLGDO-VIFPVBQESA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  26
• 可旋转键数：
  2
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.44
• 拓扑面积：
  90.3
• 氢给体数：
  2
• 氢受体数：
  8

反应信息

• 作为反应物：
  描述：

  L-精氨酸 、 (S)-9-fluoro-10-(4-hydroxypiperidin-1-yl)-3-methyl-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid 以 水 、 丙酮 为溶剂， 反应 1.0h， 以86%的产率得到(S)-9-fluoro-10-(4-hydroxypiperidin-1-yl)-3-methyl-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid L-arginine
  参考文献：
  名称：

  高效，可扩展合成喹诺酮006。

  摘要：

  喹诺酮006作为抗甲氧西林的金黄色葡萄球菌喹诺酮抗生素正在开发中。利用线性合成路​​线以多千克规模制备化合物，总产率为71％。通过控制温度和真空压力优化了工艺。描述了为了控制006活性药物成分的多态性而检查的参数的示例。

  DOI：

  10.1248/cpb.c19-00004
• 作为产物：
  描述：

  左氧氟环合酯 在 溶剂黄146 、 三乙胺 、 zinc(II) chloride 作用下， 以 水 、 乙腈 为溶剂， 反应 8.5h， 生成 (S)-9-fluoro-10-(4-hydroxypiperidin-1-yl)-3-methyl-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
  参考文献：
  名称：

  高效，可扩展合成喹诺酮006。

  摘要：

  喹诺酮006作为抗甲氧西林的金黄色葡萄球菌喹诺酮抗生素正在开发中。利用线性合成路​​线以多千克规模制备化合物，总产率为71％。通过控制温度和真空压力优化了工艺。描述了为了控制006活性药物成分的多态性而检查的参数的示例。

  DOI：

  10.1248/cpb.c19-00004

文献信息

• 一类三环喹诺酮衍生物及其制备方法和用途
  申请人：广州白云山医药集团股份有限公司白云山制药 总厂

  公开号：CN104098588B

  公开（公告）日：2016-05-25

  本发明公开了一类结构新颖的C10位外围基团为非碱性取代基取代的三环喹诺酮衍生物或其盐及其水合物，该类化合物经多种菌株进行活性测定，证明对多种敏感菌株和耐药菌株具有抗菌活性，可用于革兰氏阴、阳性细菌而引起感染疾病的治疗，特别适合于耐甲氧西林金黄色葡萄球菌（MRSA）和铜绿假单胞菌感染引起的治疗。
• SOLUBILIZED FLAVONOID COMPOSITION
  申请人：Vizuri Health Sciences LLC

  公开号：EP3345594A1

  公开（公告）日：2018-07-11

  The subject invention relates to novel soluble forms of planar ring structured organic compounds including flavonoids, and their production. The invention also includes the use of these novel formulations of planar ring structured organic compounds in the preparation of formulations and products. The invention also relates to a wide variety of applications of the formulations of the invention. The subject invention includes novel soluble forms and various formulations of flavonoids. Further, the invention includes novel methods of manufacturing the flavonoid formulations. The invention also relates to a wide variety of applications of the flavonoid formulations.

  本发明涉及平面环结构有机化合物（包括类黄酮）的新型可溶形式及其生产。本发明还包括使用这些平面环结构有机化合物的新型制剂制备配方和产品。本发明还涉及本发明制剂的多种应用。本发明包括黄酮类化合物的新型可溶形式和各种制剂。此外，本发明还包括制造类黄酮制剂的新方法。本发明还涉及类黄酮制剂的多种应用。
• Synthesis and biological evaluation of levofloxacin core-based derivatives with potent antibacterial activity against resistant Gram-positive pathogens
  作者：Xiaoguang Huang、Yingxia Bao、Shaoxuan Zhu、Xiaona Zhang、Shilong Lan、Ting Wang

  DOI：10.1016/j.bmcl.2015.07.044

  日期：2015.9

  A series of C10 non-basic building block-substituted, levofloxacin core-based derivatives were synthesized in 43-86% yield. The antibacterial activity of these new fluoroquinolones was evaluated using a standard broth microdilution technique. The quinolone (S)-9-fluoro-10-(4-hydroxypiperidin-1-yl)-3methyl- 7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid L-arginine tetrahydrate exhibited superior antibacterial activity against quinolone-susceptible and resistant strains compared with the clinically used fluoroquinolones ciprofloxacin, levofloxacin, moxifloxacin, penicillin, and vancomycin, especially to the methicillin-resistant Staphylococcus aureus clinical isolates, penicillin-resistant Streptococcus pneumoniae clinical isolates, and Streptococcus pyogenes. (C) 2015 Elsevier Ltd. All rights reserved.
• METHODS OF INCREASING SOLUBILITY OF POORLY SOLUBLE COMPOUNDS AND METHODS OF MAKING AND USING FORMULATIONS OF SUCH COMPOUND
  申请人：API Genesis, LLC

  公开号：US20140199391A1

  公开（公告）日：2014-07-17

  The subject invention relates to novel soluble forms of planar ring structured organic compounds including flavonoids, and their production. The invention also includes the use of these novel formulations of planar ring structured organic compounds in the preparation of formulations and products. The invention also relates to a wide variety of applications of the formulations of the invention. The subject invention includes novel soluble forms and various formulations of flavonoids. Further, the invention includes novel methods of manufacturing the flavonoid formulations. The invention also relates to a wide variety of applications of the flavonoid formulations.
• US8637569B2
  申请人：——

  公开号：US8637569B2

  公开（公告）日：2014-01-28